Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AESGP Welcomes EU Pharma Revision But Warns Of ‘Unintended Negative Consequences’

Apr 28 2023

• By David Ridley

EU flags at the European Commission building. Credit artJazz / iStock / Getty Images Plus

Related Content

PAGB Calls Out ‘Partial And Incomplete’ Reports Of UK OTC Cough & Cold Shortages

Jan 19 2023

OTC Shortages Top Of Mind For North American, European and Asia Pacific Consumers

Jan 26 2023

Why Did Novartis/1A Pharma Withdraw Its Paracetamol Liquid From The German Market?

Aug 25 2022

Blame The ‘Hamsters’: Germany’s Paediatric Fever Medicine Shortage Worsens

Dec 23 2022

Electronic Patient Information Leaflets Are The Future, But Paper Not Going Away Any Time Soon

Apr 15 2019

Real-World Evidence Can Play Important Role In OTC Regulation – AESGP Study

Oct 13 2021

Additional Topics

Europe EU Legislative Reform Legislation Lobbying Manufacturing NGOs OTC Drugs Pediatrics Policy Real-World Evidence Prescription To OTC Switch Intellectual Property Packaging Regulation Safety Consumer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window